UCB

News

At long last, Amgen/UCB score FDA okay for Evenity

Amgen and UCB finally have FDA approval for osteoporosis drug Evenity, two years after it was turned down by the regulator because of safety concerns.

Views & Analysis

Success comes from listening to and working with patients

With the current mainstay of Parkinson’s treatment being more than 50 years old and doing nothing to slow or halt the progressive disease, the community is crying out for new drugs.

News

Artificial neuron in concept of artificial intelligence. Wall-shaped binary codes make transmission lines of pulses and/or information in an analogy to a microchip. Neural network and data transmission.

UCB joins with UK charity to research new epilepsy drugs

Belgium’s UCB has joined forces with the UK’s Epilepsy Society in a collaboration aimed at finding treatments for people who have the disease, but do not respond to current treatments.

News

abstract shapes, bone structure, 3d render, bone

Japan approves Amgen's osteoporosis drug

Amgen’s osteoporosis bone-forming drug Evenity (romosozumab) has been approved in Japan, ahead of a crunch review by advisers to the US regulator later this month.

News

NICE okays UCB's Cimzia, nixes Almirall's Ilumetri, in psori...

NICE has recommended in draft guidance that UCB’s Cimzia can receive regular NHS funding for plaque psoriasis, but decided that Almirall’s rival Ilumetri does not represent good value for m

News

UCB, Roche, and IQVIA take lead in UK life sciences investme...

Pharma giant UCB is to invest around £1 billion in the UK as part of a second life sciences sector deal with the UK government, with industry names such as Roche and IQVIA also committing t

At long last, Amgen/UCB score FDA okay for Evenity

Success comes from listening to and working with patients

UCB joins with UK charity to research new epilepsy drugs

Japan approves Amgen's osteoporosis drug

NICE okays UCB's Cimzia, nixes Almirall's Ilumetri, in psori...

UCB, Roche, and IQVIA take lead in UK life sciences investme...

Allogeneic cell therapy isn’t dead, with Brian Culley

How to meet your physicians where they are online

UCB

Editor's Picks